Pharmaceutical

NICE recommends Pfizer’s Ritlecitinib for alopecia areata treatment

The UK NICE has recommended Pfizer's Ritlecitinib as a new treatment option for individuals suffering from alopecia areata.

Feb 24, 2024 - 18:00
NICE recommends Pfizer’s Ritlecitinib for alopecia areata treatment
The UK NICE has recommended Pfizer's Ritlecitinib as a new treatment option for individuals suffering from alopecia areata.
Read the original article

Tags:

Previous Article

Moderna reports net loss of $4.7bn for full year 2023

Next Article

AstraZeneca completes Gracell Biotechnologies acquisition for $1.2bn

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Otsuka and Astex’s oral Inaqovi wins European approval for AML

Otsuka and Astex’s oral Inaqovi wins European approval ...

Sep 19, 2023

Forbion raises $1.47bn for two life sciences-focused funds

Forbion raises $1.47bn for two life sciences-focused funds

Apr 20, 2023

Alexion and Verge enter AI-powered drug discovery deal

Alexion and Verge enter AI-powered drug discovery deal

Sep 11, 2023